Literature DB >> 29032192

Age-dependent association of thyroid function with brain morphology and microstructural organization: evidence from brain imaging.

Layal Chaker1, Lotte G M Cremers2, Tim I M Korevaar1, Marius de Groot3, Abbas Dehghan4, Oscar H Franco4, Wiro J Niessen5, M Arfan Ikram6, Robin P Peeters7, Meike W Vernooij2.   

Abstract

Thyroid hormone (TH) is crucial during neurodevelopment, but high levels of TH have been linked to neurodegenerative disorders. No data on the association of thyroid function with brain imaging in the general population are available. We therefore investigated the association of thyroid-stimulating hormone and free thyroxine (FT4) with magnetic resonance imaging (MRI)-derived total intracranial volume, brain tissue volumes, and diffusion tensor imaging measures of white matter microstructure in 4683 dementia- and stroke-free participants (mean age 60.2, range 45.6-89.9 years). Higher FT4 levels were associated with larger total intracranial volumes (β = 6.73 mL, 95% confidence interval = 2.94-9.80). Higher FT4 levels were also associated with larger total brain and white matter volumes in younger individuals, but with smaller total brain and white matter volume in older individuals (p-interaction 0.02). There was a similar interaction by age for the association of FT4 with mean diffusivity on diffusion tensor imaging (p-interaction 0.026). These results are in line with differential effects of TH during neurodevelopmental and neurodegenerative processes and can improve the understanding of the role of thyroid function in neurodegenerative disorders.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain microstructural organization; Brain morphology; Diffusion tensor imaging; Thyroid function

Mesh:

Substances:

Year:  2017        PMID: 29032192     DOI: 10.1016/j.neurobiolaging.2017.09.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  3 in total

1.  An in vivo accelerated developmental myelination model for testing promyelinating therapeutics.

Authors:  Karen Lariosa-Willingham; Kimmo K Lehtimäki; Diana Miszczuk; Dmitri Leonoudakis; Timo Bragge; Laura Tolppanen; Antti Nurmi; Megan Flanagan; Janelle Gibson; David Wilson; Jennifer Stratton
Journal:  BMC Neurosci       Date:  2022-05-25       Impact factor: 3.264

2.  TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels.

Authors:  Peter T Nelson; Zsombor Gal; Wang-Xia Wang; Dana M Niedowicz; Sergey C Artiushin; Samuel Wycoff; Angela Wei; Gregory A Jicha; David W Fardo
Journal:  Neurobiol Dis       Date:  2019-01-23       Impact factor: 5.996

Review 3.  Dementia in Down syndrome: unique insights for Alzheimer disease research.

Authors:  Ira T Lott; Elizabeth Head
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.